Ascendis Health
Dr Shavani Pillay has extensive work experience in the health industry. From July 2015 to June 2019, they worked as a Product Specialist and Trainer at Ascendis Health. In July 2019, they were promoted to the role of Drug Information and Pharmacovigilant Manager, and in July 2020, they became the Drug Information and CCO and Pharmacovigilance Manager at the same company. Prior to their time at Ascendis Health, Dr Pillay worked as a Homeopathic Practitioner starting in October 2013.
Dr. Shavani Pillay began their education in the field of homeopathic medicine and obtained a Master's degree from the Durban University of Technology. Following that, they pursued further studies at the University of Johannesburg, specializing in Complementary Reproductive Health and Fertility. In addition to their academic qualifications, Dr. Pillay also obtained a certification in Building Self-Confidence from LinkedIn in December 2020.
This person is not in any offices
Ascendis Health
Background Ascendis Health is a health and wellness company founded in 2008 and listed in the healthcare sector of the JSE in November 2013. In 2015, the Group embarked on an international growth strategy and acquired four businesses in Europe: Farmalider in Spain (2015), Remedica in Cyprus (2016), Scitec in Hungary (2016) and Sunwave Pharma in Romania (2017). Today Ascendis Health has a global reach with well-known brands and products sold to more than 120 countries across all continents. Strategic focus Against a backdrop of too much debt and limited operational flexibility we have set out a three-pillar strategy with the following focus areas: Pillar1: Stabilise (‘Fix the balance sheet’) • Set the medium-term portfolio strategy – which companies we should keep and which we should sell • Restructure existing debt to match the long-term portfolio strategy • Introduce sufficient new money to restore operational flexibility and ability to execute ‘Optimise’ Pillar Pillar 2: Optimise (‘Right-size and create platform businesses’) • Set the operating model to align with portfolio strategy and reduce complexity • Implement Project Office discipline to drive efficiencies, capital allocation optimization, and margin management strategies in each Business Unit • Create Business Unit specific incentivization programs and develop owner-manager mindsets Pillar 3: Grow (‘Maximise value and grow the platforms’) • Deleveraging strategy to take onto account the interim cash conversion profiles of the underlying business • Remain flexible to access attractive market windows • Deploy capital to underpin steady state portfolio